fda banned semaglutide Compounded Manufacturing Ban Compounded GLP-1 ban: What providers
Description
The medication's weight loss efficacyaveraging 1015% body weight reduction over 52 weeksoutweighs initial tolerability for most patients when managed properly
Last updated 11/2023
Clinical data shows that approximately 60% of patients see meaningful weight reduction at 1 mg or below, while others require higher maintenance doses for optimal effectiveness
Youve had a severe allergic reaction to this type of medication or its ingredients
Shi, I., et al., Semaglutide eligibility across all current indications for US adults, JAMA Cardiology , Nov
